AdrianaS de AraujoAndradeMD

Infectious Disease • Baltimore, MD

Assistant Professor of Medicine, Johns Hopkins University School of Medicine

Join to view full profile

Dr. Andrade is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Andrade's full profile

Already have an account?

Office
600 N Wolfe St
Baltimore, MD 21287
Phone+1 410-955-1725

Education & Training

Good Samaritan Hospital of MarylandResidency, Internal Medicine, 1996 - 1999
Federal University of Minas GeraisClass of 1991

Certifications & Licensure

MD State Medical License 1999 - 2026
American Board of Internal Medicine Internal Medicine

Clinical Trials

Study of Viral Load Decay Rates in HIV Infected Participants Starting Treatment With Raltegravir (RAL) and Emtricitabine/Tenofovir Disoproxil Fumarate (TDF) Start of enrollment: 2008 May 01
Completed
Phase 1
Intensive Viral Dynamics Substudy of A5248 Start of enrollment: 2008 May 01
Completed
Drug Interaction Study With Ribavirin and Abacavir in Male Subjects With Hepatitis C Who Have Failed Ribavirin Treatment Start of enrollment: 2009 Dec 01
Completed
Phase 1
Pharmacokinetic Interaction Study of Efavirenz and American Ginseng in Healthy Volunteers Start of enrollment: 2010 Sep 28
Completed
Phase 1
Dose-Proportionality and Intra-Individual Variability of Intracellular TFV-DP and FTC-TP in Healthy Volunteers Start of enrollment: 2011 Jan 01
Completed
Phase 1
Short-term Disulfiram Administration to Accelerate the Decay of the HIV Reservoir in Antiretroviral-treated HIV Infected Individuals Start of enrollment: 2011 Jan 01
Completed
Not Applicable
American Ginseng to Improve HIV-Associated Fatigue: A Randomized, Placebo-Controlled, Parallel Design, Multiple-Dose Clinical Trial Start of enrollment: 2013 Feb 01
Completed
Phase 2
Effects of the Probiotic Visbiome Extra Strength on Gut Microbiome & Immune Activation Markers Start of enrollment: 2016 Apr 01
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

9 citations
The pharmacokinetics, pharmacodynamics, and mucosal responses to maraviroc-containing pre-exposure prophylaxis regimens in MSM.
Ian McGowan, Timothy J. Wilkin, Raphael J. Landovitz, Chunyuan Wu, Ying Q. Chen
AIDS. 2019-02-01
4 citations
No change in health-related quality of life for at-risk U.S. women and men starting HIV pre-exposure prophylaxis (PrEP): Findings from HPTN 069/ACTG A5305.
Shashi N Kapadia, Chunyuan Wu, Kenneth H. Mayer, Timothy J. Wilkin, K. Rivet Amico
Plos One. 2018-12-26
12 citations
Genetic Variation of the Kinases That Phosphorylate Tenofovir and Emtricitabine in Peripheral Blood Mononuclear Cells.
Dominique B. Figueroa, Erin P Madeen, Joseph Tillotson, Paul G. Richardson, Leslie Cottle
AIDS Research and Human Retroviruses. 2018-05-01

Press Mentions

Probiotic to Be Studied in People Living with HIVAugust 24th, 2015
Probiotic to Be Studied in People Living with HIVFebruary 12th, 2016

Other Languages

Portuguese

External Links

Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/adriana-andrade